현대약품

004310 코스피
11,960 540 (-4.32%)
기준 : 01/23
종목진단  35점
  • 시가총액
    3,827억
  • 주식수
    3,200만
  • PER
    497.28배
  • PBR
    4.80배
  • ROE
    0.96%
  • 결산월
    11월

25.3Q 업데이트 - 잠정실적

  • 재무분석
  • 20년 재무제표
  • 손익계산서
자세히

손익계산서를 통해 매출액과 비용 그리고 이익(손실) 규모를 알 수 있습니다. 기업의 매출액에서 모든 비용을 제외하고 남는 돈을 순이익이라고 합니다. 순이익이 많을 수록 기업가치는 높아지게 됩니다.
손익계산서를 볼 때는 '많이 팔고 많이 남기는 회사'를 찾으면 됩니다. 경쟁 기업에 비해 매출액 규모가 크고, 순이익을 많이 남기면 경쟁우위에 있는 기업이라고 할 수 있습니다.

  • 데이터
  • 개별 재무제표
  • 국제회계
설정
연환산 연간 분기
세부항목 소수점
단위 : 억원
손익계산서 2025/11 2025/08 2025/05 2025/02 2024/11 2024/08 2024/05 2024/02 2023/11 2023/08 2023/05 2023/02 2022/11 2022/08 2022/05 2022/02 2021/11 2021/08 2021/05 2021/02 2020/11 2020/08 2020/05 2020/02 2019/11 2019/08 2019/05 2019/02 2018/11 2018/08 2018/05 2018/02 2017/11 2017/08 2017/05 2017/02 2016/11 2016/08 2016/05 2016/02 2015/11 2015/08 2015/05 2015/02 2014/11 2014/08 2014/05 2014/02 2013/11 2013/08 2013/05 2013/02 2012/11 2012/08 2012/05 2012/02 2011/11 2011/08 2011/05 2011/02 2010/11 2010/08 2010/05 2010/02 2009/11 2009/08 2009/05 2009/02 2008/11 2008/08 2008/05 2008/02 2007/11 2007/08 2007/05 2007/02 2006/11 2006/08 2006/05 2006/02 2005/11 2005/08 2005/05 2005/02 2004/11 2004/08 2004/05 2004/02 2003/11 2003/08 2003/05 2003/02 2002/11 2002/08 2002/05 2002/02 2001/11 2001/08 2001/05 2001/02 2000/11 2000/08 2000/05 2000/02
매출액(수익) 1,9171,917.9 1,8591,859.2 1,8051,805.8 1,7601,760.5 1,7571,757.3
내수 N/AN/A 428428.3 889889.9 1,3281,328.4 1,7561,756.1
수출 N/AN/A 00.3 00.8 11.1 11.2
기타 N/AN/A 1,8591,859.2 1,8051,805.8 1,7601,760.5 00.0
매출원가 N/AN/A 1,0911,091.9 1,0521,052.7 1,0271,027.0 1,0231,023.7
원재료 N/AN/A 249249.5 241241.8 242242.1 245245.1
재고자산의변동 N/AN/A 3030.0 3131.3 2626.7 1919.2
기타원가 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
인건비 N/AN/A 8181.7 7979.5 7676.8 7575.9
감가상각비 N/AN/A 2828.1 2727.5 2626.2 2424.4
기타 N/AN/A 702702.5 672672.2 655655.0 659659.0
매출총이익 N/AN/A 767767.3 753753.1 733733.4 733733.6
판매비와관리비 N/AN/A 746746.1 770770.6 747747.4 731731.8
급여 N/AN/A 191191.5 191191.1 187187.6 186186.4
퇴직급여 N/AN/A 1717.4 1616.9 1616.7 1616.2
복리후생비 N/AN/A 3939.5 3838.4 3535.4 3838.9
임차료 N/AN/A 00.8 00.9 00.8 00.7
수도광열비 N/AN/A 11.4 11.4 11.4 11.4
전산처리비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지급수수료 N/AN/A 7676.9 7878.6 8181.4 8181.1
용역비 N/AN/A 3939.5 3838.9 3838.4 3737.8
수출비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매수수료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매촉진비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
광고선전비 N/AN/A 117117.0 119119.6 115115.7 121121.2
애프터서비스비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
운반비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
포장비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
연구개발비 N/AN/A 171171.7 193193.6 176176.8 153153.2
개발비상각 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A -6-6.3 -5-5.3 -4-4.7 -1-1.4
감가상각비 N/AN/A 55.9 66.2 66.9 77.6
무형자산상각비 N/AN/A 77.1 66.1 55.3 44.8
기타 N/AN/A 8383.2 8383.5 8585.2 8383.6
영업이익 4141.9 2121.1 -17-17.4 -13-13.9 11.8
EBITDA N/AN/A 5858.9 2323.7 2323.7 3737.7
금융손익 N/AN/A -18-18.2 -17-17.6 -17-17.3 -16-16.8
금융수익 N/AN/A 33.6 44.5 44.8 55.5
이자수익 N/AN/A 00.3 00.5 00.9 11.6
외환거래이익 N/AN/A 00.8 11.0 00.8 11.1
외환차익 N/AN/A 11.0 00.9 00.8 11.1
외화환산이익 N/AN/A 0-0.2 00.1 00.0 00.0
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
배당금수익 N/AN/A 11.4 11.4 11.4 11.4
금융자산처분이익 N/AN/A 11.0 11.1 11.5 11.1
금융자산평가이익 N/AN/A N/AN/A 0-0.2 00.0 00.0
파생상품이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 00.0 00.4 00.0 00.0
금융비용 N/AN/A 2121.9 2222.1 2222.2 2222.3
이자비용 N/AN/A 1919.5 1919.8 2020.0 1919.8
외환거래손실 N/AN/A 22.4 22.3 22.1 22.5
외환차손 N/AN/A 22.3 22.4 22.1 22.4
외화환산손실 N/AN/A 00.0 0-0.1 00.0 00.0
기타 N/AN/A 00.0 0-0.1 00.0 N/AN/A
대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 00.0 00.0 00.0 00.0
기타영업외손익 N/AN/A -4-4.8 0-0.9 -2-2.9 -2-2.0
기타영업외수익 N/AN/A 33.5 55.3 33.3 33.4
이자수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수수료수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
임대료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
로열티수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자부동산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분이익 N/AN/A N/AN/A 00.0 00.0 00.1
무형자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손충당금환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
채무면제이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 33.5 55.3 33.3 33.3
기타영업외비용 N/AN/A 88.3 66.3 66.3 55.4
이자비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기부금 N/AN/A 00.4 00.3 00.3 11.0
투자부동산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분손실 N/AN/A 00.0 00.0 00.0 N/AN/A
무형자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손 N/AN/A 00.1 00.1 00.1 00.1
자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
사채상환손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 77.7 55.8 55.8 44.3
종속기업및관계기업관련손익 N/AN/A 00.5 00.6 00.8 0-0.3
지분법손익 N/AN/A 00.5 00.6 00.8 0-0.3
지분법이익 N/AN/A 00.6 00.4 00.1 N/AN/A
지분법손실 N/AN/A 0-0.1 00.1 00.6 0-0.3
지분법적용투자주식손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 00.5 00.6 00.8 N/AN/A
관계기업처분손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A